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 PP2Ce is Ser-Thr phosphatase specifically
localized on SR and expressed in
cardiomyocytes.
 PP2Ce has specific phosphatase activity to
dephosphorylate Thr-17 site of
phospholamban.
 PP2Ce expression is induced upon
pathological stress, including beta-AR
stimulation and ROS.
 PP2Ce induction suppresses
cardiomyocyte calcium cycling, reduces
beta-AR-induced contractility, and pro-
motes oxidative ischemia/reperfusion
injury.
 PP2Ce is a new molecular component of
stress-mediated cardiomyocyte calcium
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161SUMMARY
AB BAND ACRONYM S
CaMKII = calmodulin kinase II
ER = endoplasmic reticulum




NRVM = neonatal rat
ventricular myocyte
PLN = phospholamban
PP1 = protein phosphatase 1
PP2A = protein phosphatase 2APhospholamban (PLN) is a key regulator of sarcolemma calcium uptake in cardiomyocyte; its inhibitory activity
to sarcolemma-endoplasmic reticulum calcium ATPase is regulated by phosphorylation. PLN
hypophosphorylation is a common molecular feature in the failing heart. The current study provided evidence
at the molecular, cellular, and whole-heart levels to implicate a sarcolemma membrane-targeted protein
phosphatase, PP2Ce, as a specific and potent PLN phosphatase. PP2Ce expression was elevated in failing
human heart and induced acutely at protein level by b-adrenergic stimulation or oxidative stress in
cardiomyocytes. PP2Ce expression in mouse heart blunted b-adrenergic response and exacerbated
ischemia/reperfusion injury. Therefore, PP2Ce is a new regulator for cardiac function and pathogenesis. (J Am
Coll Cardiol Basic Trans Science 2017;2:160–80) © 2017 The Authors. Published by Elsevier on behalf of the
American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).e = protein phosphatasePP2C2C on ER membrane




SR = sarcoplasmic reticulum
TUNEL = transferase dUTP
end labelingH eart disease is a leading cause of death inthe United States. Defects in intracellularCa2þ homeostasis have been implicated in
the onset and progression of heart failure (1–6), which
lead to a blunted response to adrenergic stimulation
and loss of contractility (7–9). Cardiac sarcoplasmic
reticulum (SR) Ca2þ cycling, involving Ca2þ-induced
Ca2þ release from SR through the ryanodine receptor
(RyR2) during systole, and Ca2þ uptake via SR
calcium-ATPase 2a (SERCA2a), is central to cardiac
contraction and relaxation (10). This process is tightly
regulated by reversible phosphorylation of an
SR-targeted protein phospholamban (PLN), a key
negative regulator for SERCA2a activity (11). PLNSEE PAGE 181phosphorylation by PKA at the Ser-16 site and by
calmodulin kinase II (CaMKII) at the Thr-17 site
releases its inhibition to SERCA2a activity, resulting
in elevated SR Ca2þ uptake and accelerated intracel-
lular Ca2þ decline during relaxation. This is a major
mechanism contributing to the enhanced contrac-
tility in response to adrenergic and other stimula-
tion (12). In addition to its fundamental role in
mediating myocyte contraction, PLN-mediated Ca2þ
regulation also plays a crucial role in cardiomyocyte
cell death regulation, especially following myocar-
dial infarction (MI) (13). Depressed SR Ca2þ cycling
in the post-MI heart contributes to intracellular
Ca2þ overload, which in turn leads to myocyte ne-
crosis and apoptosis (14,15). Compared with our
extensive studies of the protein kinases involved
in PLN regulation, our insights into the PLN-
specific phosphatases responsible for its dephos-
phorylation are relatively limited. Previous studies
have revealed that protein phosphatase-1 (PP1), a
relatively nonselective ser/thr protein phosphatase,contributes to a significant level of PLN
phosphorylation regulation at both Ser-16
and Thr-17 sites (11,16–18). In addition, pro-
tein phosphatase 2A (PP2A) subunit B56
also mediates targeted dephosphorylation
of PLN Ser-16 in addition to other cardiac
proteins. PLN hypophosphorylation is a common
molecular feature in the failing hearts and muta-
tions of PLN that affect its phosphorylation and
interaction with SERCA2a lead to cardiomyopathy
in humans (16,17,19–25). Therefore, there is a need
to better understand the underlying mechanism
for PLN dephosphorylation and the relevant
proteins.
In this report, we characterized an ER-targeted
member of the protein phosphatase 2C family,
PP2Ce, in the heart. PP2Ce messenger ribonucleic
acid (mRNA) was detected in the heart. In car-
diomyocytes and a cell-free system, PP2Ce showed
high specificity toward the Thr-17 site of PLN, and its
expression significantly suppressed b-adrenergic
stimulation-induced calcium transients and exacer-
bated cell death upon oxidative stress. Expression of
PP2Ce mRNA was found to be elevated in human
cardiomyopathy hearts, and its protein was shown to
be acutely induced in myocytes by pathological
stressors via modulation of protein homeostasis.
Cardiac-specific expression of PP2Ce in a transgenic
mouse model led to hypophosphorylation of PLN
associated with exacerbated cardiac dysfunction and
injury following ischemia/reperfusion (I/R). There-
fore, PP2Ce is a novel SR membrane-targeted and
specific phosphatase for PLN in cardiomyocytes, and
its induction under pathological conditions may
have a significant contribution to PLN hypo-
phosphorylation, cardiomyocyte dysfunction and
death.
nick
FIGURE 1 PP2Ce is an ER Membrane-Targeted Protein Phosphatase and Detected in Adult Mouse Hearts
(A) Schematic description of protein phosphatase 2C on endoplasmic reticulum (ER) membrane (PP2Ce) protein with signal peptide
sequence (aa20-40), transmembrane domain, and conserved PP2C phosphatase activity domain highlighted. (B) Northern-blot
analysis of PP2Ce messenger ribonucleic acid (mRNA) expression in different tissues from adult mice with significant expression
detected in in the brain, heart, and diaphragm. (C) Immunohistochemistry results displayed PP2Ce (green) was colocalized with
sarcolemma-endoplasmic reticulum calcium ATPase (SERCA) 2a (red) in adult rabbit ventricular cardiomyocytes as supported in
merged image and line-scanning intensity analysis. (D) Relative expression of PP2Ce mRNA detected by quantitative real-time
polymerase chain reaction in heart samples from ischemic cardiomyopathy (ICM) (n ¼ 3) and dilated cardiomyopathy (DCM) (n ¼ 3)
compared with non-heart failure hearts (normal, n ¼ 3). *p < 0.05 versus normal.
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GENERATION OF CARDIAC-SPECIFIC AND INDUCIBLE
PP2Ce MICE (PP2Ce TG). Double transgenic PP2Ce
mice were generated by crossing PP2Ce single trans-
genic line to a strain carrying the tetracycline-
controlled transactivator gene (tTA), which is under
the regulation of the alpha-myosin heavy chain pro-
moter. Enhanced PP2Ce expression was achieved
upon withdrawal of doxycycline. Control animals
used in this study were littermate mice carrying single
transgenic tTA. Male mice between age 10 to 15 weeks
were used in the present study. All experiments were
conducted in accordance with University of Califor-
nia, Los Angeles, animal welfare guidelines.ECHOCARDIOGRAPHY. Mice were anesthetized with
1% isoflurane. Echocardiography was quantified on
2-dimensional M-mode along the short-axis of the left
ventricle using the Vevo 770 system (VisualSonics,
Toronto, Ontario, Canada) and analyzed using the
software suite provided by the vendor.
ISOLATION OF ADULT CARDIOMYOCYTES AND
MEASUREMENT OF Ca2D TRANSIENTS. Rat adult
ventricular cardiomyocytes were enzymatically iso-
lated in the following procedure. Hearts were quickly
removed and retrogradely perfused with Ca2þ-free
Tyrode’s buffer containing collagenase II until
hearts became softer (w10 min). Calcium transients
recording and measurement were performed as pre-
viously described (26).
FIGURE 2 PP2Ce Expression on ER Stress Signaling Pathway in NRVM
(A) Representative immunoblot of ER stress regulators as indicated in NRVM expressing GFP and PP2Ce in response to 50 mmol/l H2O2
treatment at specific time points as indicated. The 5 mg/ml tunicamycin-treated NRVM was used as a positive control. (B) Quantification of
immunoblot signals with independent experimental replicate number labeled in each column. **p < 0.01. ER ¼ endoplasmic reticulum;
GFP ¼ green fluorescent protein; NRVM ¼ neonatal rat ventricular myocyte; PP2Ce ¼ protein phosphatase 2C on ER membrane.
Continued on the next page
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163I/R IN ISOLATED HEART. The ex vivo I/R model was
performed as previously described (27). Briefly, the
heart was perfused in the Langendorff system at a
constant pressure of 80 mm Hg by gravity. A fluid-
filled balloon was inserted into the left ventricle
and connected to a pressure transducer for contin-
uous recording of left ventricular pressure and heart
rate. After 30 min of stabilization, hearts were sub-
jected to 30 min of global normothermic (37oC)
ischemia followed by up to 120 min of reperfusion.
Heart tissues were collected for further studies.
Infarct size measurement was performed by triphe-
nyltetrazolium chloride (TTC) staining, and
apoptosis-positive cells were characterized by ter-
minal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) staining.
COMPLEMENTARY DEOXYRIBONUCLEIC ACID SYNTHESIS
AND QUANTITATIVE REAL-TIME POLYMERASE CHAIN
REACTION ANALYSIS. Total RNA was extracted from
the left ventricle with TRIzol reagent (Invitrogen,
Carlsbad, California) according to the manufac-
turer’s instructions. Five micrograms of total RNAwere used to reverse-transcribe the first-strand com-
plementary deoxyribonucleic acid with a Superscript
first-strand synthesis kit (Invitrogen). Complementary
deoxyribonucleic acid transcripts were quantified by
the iCycler iQ real-time polymerase chain reaction
detection system using iQ SYBR Green Supermix
(Bio-Rad, Hercules, California). Glyceraldehyde 3-
phosphate dehydrogenase mRNA was used for
normalization. Each reaction was performed in
duplicate.
WESTERN BLOT AND IMMUNOPRECIPITATION
ASSAY. Western blots were performed as described
previously (26). A total of 10 to 50 mg of total protein
from ventricles and myocytes was loaded on 4%
to 12% Bis-Tris gel, followed by electric transfer
to nitrocellulose membranes. All protein signals
were digitally recorded and quantified based on
intensities, presented as average  SD.
IN VITRO DEPHOSPHORYLATION ASSAY. Left
ventricle tissue extract was prepared in lysis
buffer (50 mmol/l Tris-HCl [pH 7.4], 150 mmol/l
NaCl, 1% Nonidet P-40, and 1 mmol/l
FIGURE 2 Continued
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FIGURE 3 PP2Ce is a Specific Phosphatase for PLN Thr-17 Phosphorylation Site
(A) Representative immunoblot from NRVM-expressing GFP or PP2Ce were treated with 1 mmol/l isoproterenol for 0.5 and 2 h as indicated.
(B) Quantification of immunoblot signals with independent experimental replicate number labeled in each corresponding column. (C)Western
blot for NRVM coexpressing active CaMKII (CaMKII-CA) and increasing amount of PP2Ce as indicated. *p < 0.05; **p < 0.01 versus untreated;
and #p < 0.05; between PP2Ce and GFP at each time point. PLN ¼ phospholamban; other abbreviations as in Figure 2.
Continued on the next page
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tein inhibitors (Roche Diagnostics, Indianapolis,
Indiana) and incubated with 1 ug of monoclonal
antiphospholamban antibody (Thermo Scientific,
Waltham, Massachusetts) for 2 h at 4oC. The
tissue lysate then was incubated with 60 mg of protein
A/G-agarose for 2 h at 4oC. After washing 4 with
washing buffer (20 mmol/l Tris-HCl (pH 7.4), 150
mmol/l NaCl, and 1% Nonidet P-40), the beads
were incubated with 2 mg of glutathione S-transferase
(GST) or GST fusion protein in 20 ml of reaction
buffer containing 20 mmol/l 4-(2-hydroxyethyl)-1-
piperazine-ethanesulfonic acid (pH 7.4), 20 mmol/l
MgCl2, 2 mmol/l dithiothreitol, and 200 mmol/l ATP
at 37oC for 1 h. The reaction was terminated by
adding NuPAGE LDS sample buffer (Invitrogen) con-
taining 10% b-mercaptoethanol and boiling for
10 min. Samples were subjected to sodium dodecyl
sulfate polyacrylamide gel electrophoresis.ASSESSMENT OF INFARCT AREA. After 120 min of
reperfusion, hearts were perfused with a TTC 1%
solution for 5 min and frozen at 20oC. The hearts
were sliced into 6 (1-mm thickness/slice) cross sec-
tions. Viable myocardium showed red, and the
infarct area showed pale white. Each slice image
was recorded digitally using a camera mounted on a
dissecting scope. The total and infarct area of
ventricle of each slice were visually demarcated
and measured using SPOT image analysis software
(Sterling Heights, Michigan). The relative infarction
was calculated as the percentage of infracted area
over the total ventricular area.
TUNEL STAINING. To detect apoptotic cells, a TUNEL
assay was performed using the Apoptag kit (Invi-
trogen). Cross sections (5 mm) from frozen hearts
(6 sections/heart) were prepared. Nuclei were
counterstained with 4,6-diamidino-2-phenylindole,
FIGURE 3 Continued
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167cardiomyocytes were labeled with a-actin, and the
percentage of TUNEL-positive cardiomyocytes cells
was calculated from total TUNEL-positive myocyte
nuclei versus total 4,6-diamidino-2-phenylindole–
labeled myocyte nuclei.
MTT ASSAY. Neonatal rat ventricular myocytes
(NRVMs) were plated out in 100 ul of medium at a
concentration of 5  104 cells in 96-well culture plates
and cultured in an incubator at 37C in an atmosphere
of 5% CO2 in air. After 36 h of adenovirus infection,
NRVMwere treated with hydrogen peroxide (H2O2: 20,
50, or 100 mmol/l for 16 h) or 100 mmol/l of H2O2 for 2, 8,
and 16 h. A total of 10 ul of 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT 5mg/ml,FIGURE 4 Specificity of PP2Ce Activity to PLN Thr-17 Phosphorylation
(A) Immunoblot of PP2Ce, GFP, and PLNphosphorylation (Ser-16 and Thr-17) inNRVMexpressingGFP or PP2Cewild-type or PP2Ce phosphatase
dead mutant (D320A) following 1 mmol/l isoproterenol treatment at different time points as indicated. (B) ISO-induced PP2Ce expression and
PLN phosphorylation in NRVM-expressing PP2Ce truncationmutant (⊿1–57), which has lost ER targeting capacity (28,29). (C) PP2Ce–GST fusion
protein was incubated with PLN isolated from NRVM with or without ISO treatment, followed by immunoblot for total and phosphorylation
levels of PLN at Ser-16 and Thr-17. (D) Coimmunoprecipitation of PP2Ce and PLN inmouse heart using PP2Ce TG and PP2Ce KO as positive and
negative control, respectively. ISO ¼ isoproterenol; TG ¼ transgenic; other abbreviations as in Figures 2 and 3.
FIGURE 5 ISO-Mediated Regulation of PP2Ce Protein in Cardiomyocytes
(A) PP2Ce and PP2Ca expression in NRVM following ISO treatment. (B) PP2Ce expression in NRVM treated with ISO (1 mmol/l) with or without
cotreatment of proteasome inhibitor MG132 (10 mmol/l) or lysosomal inhibitor BAF (50 nmol/l) as indicated. (C) Quantification of PP2Ce
expression in NRVM treated with ISO with or without additional treatment of cycloheximide (CHX), MG132, or BAF as indicated. (D) PP2Ce
expression in NRVM-treated ISO or forskolin (FSK) at 0.1, 1, and 10 mmol/l concentrations as indicated. (E) PP2Ce expression in NRVM treated
with FSK (1 mmol/l) with or without PKA inhibitor H89 (1 mmol/l) as indicated. n indicates the number of total experimental replicates.
*p < 0.05; **p < 0.01. Abbreviations as in Figures 2 to 4.
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168dissolved in phosphate-buffered saline) was added to
each well. After 3 h incubation in the dark, NRVMs
werewashed and lysed to release formazan, whichwas
subsequently dissolved in 100 ml of dimethyl sulf-
oxide. The absorbance was recorded in a microplate
reader (Synergy H1, BioTek Instruments, Winooski,
Vermont) at a wavelength of 570 nm. Results were
normalized for the control group.
STATISTICAL ANALYSIS. Data are presented as
mean  SD. Means between 2 experimental groups
were compared with an unpaired Student t test or
Mann-Whitney U test. Multigroup comparisons wereperformed by Kruskal-Wallis test, 2-way analysis of
variance, and repeated measure analysis of variance.
Multiple comparisons were performed by Stell
method and Bonferroni correction. A p value <0.05
was considered statistically significant.
RESULTS
IDENTIFICATION OF PP2Ce AS AN ER/SR
MEMBRANE-TARGETED PROTEIN PHOSPHATASE IN
CARDIOMYOCYTES. In previous studies, we reported
that PP2Ce had targeted localization on the
FIGURE 6 Functional Effect of PP2Ce Expression on SR Calcium Homeostasis in Adult
Rat Cardiomyocytes
(A) Representative images of calcium transients from control rat myocytes at basal and
following ISO (0.1 mmol/l) treatment. (B) Representative recording of calcium signal
(F/F0) at basal and post-ISO treatment in LacZ-expressing rat adult cardiomyocytes.
(C) Representative recording of calcium signal at basal and post-ISO treatment in PP2Ce-
expressing rat adult cardiomyocytes. (D) Summary data of changes in calcium amplitude
and decay time in adult cardiomyocytes expressing LacZ (n ¼ 5) versus PP2Ce (n ¼ 3)
between basal and post-ISO treatment. *p < 0.05; **p < 0.01 LacZ versus PP2Ce,
respectively. ⊿ ¼ the difference between post- and pre-ISO treatment; other
abbreviations as in Figures 2 to 4.
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169endoplasmic reticulum (ER) membrane (28,29)
(Figure 1A). In fat cells and mammary glands, PP2Ce
possesses highly specific activity toward IRE1, a key
signal molecule for ER stress response and serves as a
negative feedback modulator to ER stress signaling,
with a significant role in adiposity and lactating
activity (28,29). By Northern blot analysis from
tissues of adult mice, PP2Ce mRNA was also detected
at substantial levels in the brain, heart, and dia-
phragm (Figure 1B). Using immunofluorescent
microscopy, we confirmed that the full-length
PP2Ce protein was specifically targeted on the SR
membrane in adult rat cardiomyocytes, colocalizing
with the SERCA2a (Figure 1C). Furthermore, PP2Ce
the mRNA level was elevated in human ischemia
cardiomyopathy or dilated cardiomyopathy hearts
comparing with the nonfailing control subjects
(Figure 1D). However, overexpressing PP2Ce in
cultured NRVMs did not significantly affect ER
stress response pathway, including phosphor-PERK
and phosphor-elF2a, as well as BiP and Xbp1 expres-
sion under basal or oxidative stress (Figure 2B),
although there was a modest reduction in CHOP
and activated caspase 3.
FUNCTION OF PP2Ce IN CARDIOMYOCYTES AS A
PLN-SPECIFIC PHOSPHATASE. Considering the
fact that PP2Ce is an SR-targeted protein phospha-
tase with substantial cardiac expression, we investi-
gated the effect of PP2Ce expression on the
phosphorylation of several SR membrane proteins
in cardiomyocytes under basal or post-isoproterenol
(ISO) treatment. As shown in Figures 3A and 3B,
PP2Ce expression did not markedly affect RyR2
phosphorylation at either PKA (Ser-2808) or CaMKII
(Ser-2814)–targeted sites or the phosphorylation
levels of other cytosolic proteins, such as troponin I.
In contrast, PP2Ce expression potently blocked
ISO-induced PLN phosphorylation at the Thr-17
residue, with a relatively more modest effect
on its Ser-16 phosphorylation under the same condi-
tion. To evaluate whether PP2Ce-induced PLN Thr-17
dephosphorylation was achieved by inhibiting
CaMK activity or by directly targeting PLN, we
tested the effect of PP2Ce expression on CaMK
activity. As shown in Figures 3A and 3B, PP2Ce
expression did not markedly affect the basal or the
ISO-induced autophosphorylation levels of CaMKII.
Furthermore, when we coexpressed PP2Ce and
a constitutively active form of CaMKII (CA) in
NRVM, the PLN Thr-17 phosphorylation induced
by the CaMKII-CA expression was markedly abol-
ished (Figure 3C), further supporting PLN as a
molecular target of PP2Ce. To demonstrate thedirect phosphatase activity of PP2Ce toward PLN,
we expressed a phosphatase dead mutant (D302A)
(Figure 4A) and deletion mutant PP2Ce without ER
FIGURE 7 Effect of PP2Ce on Calcium Homeostasis in Intact Mouse Heart
(A) Schematic drawing of PP2Ce-transgenic mouse with tissue-specific expression of PP2Ce in heart. (B) PP2Ce protein expression in mouse
hearts from 4 genotypes carrying either none, single, or double transgenes of aMHC-tTA expressing tet-off suppressor (tTA) and aHMC-
TetO-PP2Ce (iPP2Ce). PP2Ce expression was detected only from double transgenic hearts in the absence of tetracycline. PC is the positive
control from NRVM-expressing adv-PP2Ce. (C) Representative immunoblot analysis. (D) Quantification of key proteins involved in calcium
homeostasis regulation in control and PP2Ce transgenic (TG) hearts. Number of replicates is labeled in each column. (E) Calcium transient
peak amplitudes (F/F0), time to peak and decay measured from isolated cardiomyocytes of control (n ¼ 8) and PP2Ce TG (n ¼ 8) hearts.
*p < 0.05; **p < 0.01. Abbreviations as in Figures 2 to 4.
Continued on the next page
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these PP2Ce mutants showed no marked effect on
PLN phosphorylation under ISO stimulation. These
data suggest the PP2Ce-mediated PLN dephosphory-
lation requires both phosphatase activity and ER
membrane localization. To further support its direct
function and specificity, we generated recombinant
GST-fusion proteins for the wild-type and a phos-
phatase dead mutant of PP2Ce, and incubated the
recombinant PP2Ce or PP2Ce-mutant proteins with
PLN proteins prepared by immunoprecipitation from
ISO-treated mouse left ventricle tissues where both
Ser-16 and Thr-17 sites were highly phosphorylated.
In this cell-free system, PP2Ce did not affect PLN
phospho-Ser-16 levels, but effectively diminished
the phospho-Thr-17 level (Figure 4C), supporting
that dephosphorylating the PLN-Thr-17 is a direct
and specific intrinsic activity of PP2Ce. Finally, by
coimmunoprecipitation assay, we demonstrated
protein–protein interaction between PLN and PP2Ce
in intact mouse hearts (Figure 4D). All of these
data suggest that PP2Ce is a novel PLN phosphatase
with a highly specific intrinsic phosphatase activity
toward phosphor-Thr-17.POST-TRANSCRIPTIONAL REGULATION OF PP2Ce
EXPRESSION IN CARDIOMYOCYTES. Because there
is no commercial antibody sufficiently sensitive
to detect the endogenous PP2Ce protein in car-
diomyocytes, we followed the expression of
PP2Ce-Flag fusion protein introduced into NRVM
(Figures 3 to 5). Stimulation of NRVM with ISO
significantly and consistently induced PP2Ce protein
level as early as 2 h after treatment (Figure 3B). This
induction is specific to PP2Ce, as ectopic expression
of green fluorescent protein (GFP) or another PP2C
family member, PP2Ca, using the same expression
vectors were not affected by ISO treatment within the
same time period (Figures 3B and 5A). The ISO-
mediated induced PP2Ce protein was significantly
blunted by protein synthesis inhibition (Figures 5B
and 5C) but further increased by short-term protea-
some inhibition (Figures 5B and 5C). Therefore, ISO-
mediated PP2Ce induction involved protein synthe-
sis and degradation. Direct induction of cAMP by
forskolin treatment was sufficient to induce the same
pattern of PP2Ce protein increase (Figure 5D). How-
ever, PKA inhibition by treating cells with H89
markedly blocked ISO-mediated PP2Ce induction
FIGURE 7 Continued
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172(Figure 5E). In addition to b-adrenergic stimulation,
oxidative stress induced by superoxide treatment
also increased PP2Ce protein level in cardiomyocytes
as early as 8 h (Figures 2A and 2B). This evidence
suggests that PP2Ce expression is subjected to dy-
namic regulation at protein level in response to
pathological stressors in cardiomyocytes. Such in-
duction can serve as an intrinsic and local negative
modulator for b-adrenergic signaling by specifically
targeting PLN Thr-17 phosphorylation.
FUNCTIONAL EFFECT OF PP2Ce IN CARDIOMYOCYTES.
As we established PLN as a specific substrate of
PP2Ce and a key modulator of SR calcium homeosta-
sis, we investigated the physiological effect of
PP2Ce on SR calcium cycling in cardiomyocytes. We
measured the effect of PP2Ce expression on SR
calcium cycling in isolated adult rat ventricular
cardiomyocytes. As shown in Figure 6, expression
of PP2Ce did not affect basal calcium transient but
significantly reduced the intracellular peak calcium
amplitude and slowed the calcium transient decline
rate following ISO stimulation, supporting the
functional effect of PP2Ce expression on SR calcium
cycling consistent with its targeted dephosphoryla-
tion of PLN.TABLE 1 Echocardiogram Parameters Measured From Nontransgenic
HR (beats/min) LVPW(s) (mm) LVPW
Control (n ¼ 41) 484  86 1.00  0.12 0.66
TG (n ¼ 33) 479  36 1.06  0.14* 0.68
Values are mean  SEM. *p < 0.05; †p < 0.01 between control and TG groups.
(d) ¼ diastolic; FS ¼ fractional shortening; HR ¼ heart rate; LVID ¼ left ventricle
TG ¼ transgenic.To further determine the functional role of PP2Ce
in the intact heart, we developed a transgenic mouse
model with cardiac-specific expression of PP2Ce
(PP2Ce-TG) (Figure 7A). Western blots revealed
that PP2Ce expression was induced in the transgenic
heart specifically in double transgenic animals
(Figure 7B). Consistent with previous in vitro obser-
vations at the basal level, the PP2Ce-TG mice exhibi-
ted normal cardiac phenotype at morphological
and functional levels (Table 1). Also, consistent with
the in vitro results, the basal PLN phosphorylation
at Thr-17 was significantly inhibited, although in
this case, Ser-16 phosphorylation was also reduced
(Figures 7C and 7D). In contrast, the phosphorylation
levels of RyR2 at both PKA- and CaMKII-dependent
sites and the phosphorylation levels of troponin I
were not changed, nor were the total protein levels
for RyR2, troponin I, SERCA-2a, and sodium-calcium
exchanger 1 (Figures 7C and 7D). Notably, PP1
expression was not affected by PP2Ce expression.
In isolated intact left ventricular cardiomyocytes
loaded with Fluo-4 AM (Ca2þ fluorescent dye) and
paced at 1 Hz by an electric stimulator (Figure 7E), the
50% decay time of Ca2þ transients was signifi-
cantly prolonged in the PP2Ce-TG myocytes
(average 159.4 ms) relative to the non-TG controland PP2Ce Transgenic Hearts
(d) (mm) LVID(s) (mm) LVID(d) (mm) FS (%)
 0.12 2.86  0.34 4.13  0.33 31.1  4.8
 0.15 2.70  0.23* 4.11  0.23 34.0  4.7†
internal dimension; LVPW ¼ left ventricle posterior wall thickness; (s) ¼ systolic;
FIGURE 8 PP2Ce Expression Impairs ISO Stimulated Enhancement of Contractility
(A) Representative left ventricle pressure (LVP) measured from isolated hearts of wildtype or PP2Ce TG mice at basal or perfused by 1 mmol/l
of ISO. (B) Hemodynamic parameters from control (n ¼ 9) and PP2Ce TG (n ¼ 6) hearts at basal or treated by 10 nmol/l ISO. *p < 0.05;
**p < 0.01 between basal and I/R within control or PP2Ce TG groups. #p < 0.05 between corresponding control and PP2Ce TG. dP/dt
max ¼ maximal systolic pressure derivative; dP/dt min ¼ maximal diastolic pressure derivative; HR ¼ heart rate; I/R ¼ ischemia/reperfusion;
LVDP ¼ left ventricle developed pressure (Pmax  Pmin); Pmax ¼ systolic pressure; Pmin ¼ diastolic pressure; Tau ¼ relaxation index; other
abbreviations as in Figures 2 to 4.
J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 2 , N O . 2 , 2 0 1 7 Akaike et al.
A P R I L 2 0 1 7 : 1 6 0 – 8 0 PP2Ce Regulates Phospholamban Phosphorylation
173
TABLE 2 Hemodynamic Parameters
Control (n ¼ 9) TG (n ¼ 6)
Basal I/R Basal I/R
HR, beats/min 403.5  96.4 334.7  87.2 390.0  74.6 281.8  49.9
Pmax, mm Hg 91.22  20.67 95.50  10.60 98.55  17.72 94.35  10.42
Pmin, mm Hg 3.68  2.30 39.71  12.52* 4.28  2.44 55.03  11.26*†
dP/dt max, mm Hg/s 4,794.9  446.4 2,906.0  490.8* 4,942.2  871.5 1,839.8  411.0*‡
dP/dt min, mm Hg/s 3,031.6  359.8 1,867.3  235.3* 3,156.9  435.6 1,225.6  344.6*‡
LVDP, mm Hg 87.54  18.76 55.79  8.31* 94.27  18.45 39.33  11.64*
Values are mean  SEM. Cardiac performance was measured from isolated nontransgenic (control, n ¼ 9) and the PP2Ce TG (n ¼ 6) hearts under basal and
post-30-min global ischemia and 45-min reperfusion (I/R). *p < 0.01 between basal and I/R within control or TG groups. †p < 0.05; ‡p < 0.01 between corre-
sponding control and TG groups.
dP/dt max ¼ maximal systolic pressure derivative; dP/dt min ¼ maximal diastolic pressure derivative; LVDP ¼ left ventricle developed pressure (Pmax  Pmin);
Pmax ¼ systolic pressure; Pmin ¼ diastolic pressure; other abbreviations as in Table 1.
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were no significant differences in the peak Ca2þ
transient amplitude or the time to peak of Ca2þ
transients between the PP2Ce-TG myocytes and
control subjects (Figure 7E).
PP2Ce EXPRESSION IMPAIRS INOTROPIC RESPONSE
TO ISOPROTERENOL. To directly examine the func-
tional effect of PP2Ce expression on cardiac contrac-
tile function and isoproterenol response, we
measured left ventricular pressure in isolated
perfused hearts from nontransgenic and PP2Ce
transgenic mice. As shown in Figure 8, the PP2Ce
transgenic hearts had similar contractile function
at the basal condition (Figure 8, Table 2) but showed
a blunted response to isoproterenol stimulation
compared with wild-type control hearts based on
systolic pressure, dP/dTmax, and dP/dT min, as
well as left ventricle developed pressure (Figure 8B).
This is consistent with in vitro calcium measurement
observed in isolated myocytes (Figure 7).
PP2Ce EXPRESSION REDUCED FUNCTION RECOVERY
POST-I/R INJURY. CaMKII-mediated Thr-17 phosphor-
ylation of PLN has been implicated in I/R injury
and cardiomyocyte death regulation (13–15). There-
fore, we investigated the effect of PP2Ce expression
in the intact PP2Ce-TG hearts during I/R injury. Using
a Langendorff preparation, the isolated mouse hearts
from the PP2Ce-TG and the control mice were sub-
jected to 30 min of global no-flow ischemia followed
by 60 to 120 min of reperfusion (I/R) while contrac-
tility was continuously monitored via a conductance
catheter for left ventricle pressure (Figure 9A). As
shown in Figure 9B, the functional recovery following
reperfusion was significantly impaired in the PP2Ce-
TG transgenic hearts compared with the controls.
Particularly, after 45 min of reperfusion, systolicfunction as measured from left ventricle developed
pressure (PP2Ce-TG vs. control: 39.33  11.64 mm Hg
vs. 55.79  8.3 mm Hg; p < 0.01) (Figure 9B) and
dP/dTmax (PP2Ce-TG vs. control: 1,839.78  410.98
mm Hg/s vs. 2,905.99  490.76 mm Hg/s; p < 0.01)
was significantly reduced in the PP2Ce-TG hearts
compared with the controls (Figures 9A to 9D,
Table 2). In addition, cardiac relaxation as measured
from dP/dT min (PP2Ce-TG vs. control: 1,274.42 
239.59 mm Hg/s vs. 1,707.4  190.53 mm Hg/s;
p < 0.05) (Figure 9D) and Tau (PP2Ce-TG vs. control:
46.7  21.4 ms vs. 23.3  5.5 ms; p < 0.05) (Figure 9E)
were also significantly impaired in the PP2Ce-TG
hearts compared with the control hearts at 60 min
post-reperfusion. These data demonstrated exacer-
bated systolic and diastolic dysfunction following I/R
injury on PP2Ce expression in the heart. Along with
impaired functional recovery, myocardial infarct size
as measured by TTC staining (infarct area vs. area at
risk) at 120 min post-reperfusion was significantly
larger in the PP2Ce-TG hearts compared with the
control hearts (infarct area/area at risk: 59.82  6.10%
vs. 40.06  6.71%; p < 0.01) (Figures 10A and 10B).
Additionally, using TUNEL staining, more apoptotic
cells were detected in the PP2Ce9-TG heart than the
control hearts (Figure 10C). To further support the
status of impaired cardiac protection by PP2Ce
expression, mitochondrial-mediated apoptotic cell
death signaling as represented by cleaved caspase
9 was detected to be significantly induced in the
PP2Ce-TG hearts compared with control hearts
following I/R (Figures 10D and 10E).
PP2Ce EXPRESSION PROMOTES OXIDATIVE STRESS-
INDUCED CELL DEATH IN CARDIOMYOCYTES. We
next investigated whether PP2Ce expression directly
affects myocyte survival under oxidative stress
in vitro. NRVMs showed dosage-dependent cell death
FIGURE 9 PP2Ce Expression Impairs Function Recovery Following Ischemia/
Reperfusion Injury
(A) Left ventricle dP/dt max during 15-min global ischemia followed by 60-min reper-
fusion in isolated hearts from nontransgenic control subjects (control, n ¼ 9) and PP2Ce
TG (TG, n ¼ 6) mice. Left ventricle function parameters measured as (B) left ventricular
developed pressure (LVDP), (C) systolic pressure increase (dP/dt max), (D) diastolic
pressure decrease (dP/dt min), and (E) relaxation time index (Tau) in nontransgenic
control subjects (control, n ¼ 9) and PP2Ce TG hearts (n ¼ 6) at basal and 45 min after
reperfusion. **p < 0.01 between control and PP2Ce TG groups. #p < 0.05; ##p < 0.01
between corresponding control and PP2Ce TG groups at each time point.
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up to 16 h based on MTT assay. Following PP2Ce
expression, the NRVM showed significantly reduced
cell viability upon H2O2 or ionomycin treatment
compared with the GFP-expressing cells (Figures 11A
and 11B). To explore the signaling mechanism
involved in this process, we examined AKT and
mitogen-activated protein kinase pathways. As
shown in Figures 11C and 11D, PP2Ce expression
significantly reduced pro-survival AKT and extracel-
lular signal-regulated kinase activity following
oxidative stress without significantly affecting pro-
death stress MAPK activities, including p38 and
c-jun N-terminal kinase. In line with the role of PP2Ce
in SR calcium regulation, calcium overload-induced
cell death triggered by ionomycin treatment for 24 h
was also significantly enhanced by PP2Ce expression
(Figure 11B). Taken together, PP2Ce expression
promotes oxidative injury via enhanced myocyte
death associated with disturbance in intracellular
signaling.
DISCUSSION
In this report, we characterized a newly identified
protein phosphatase PP2Ce in cardiomyocytes
in terms of its molecular target and cellular/
physiological function in the heart. Our findings
establish that PP2Ce is localized on the SR mem-
brane overlapping with SR calcium ATPase 2a. PP2Ce
expression is significantly induced at the mRNA
level in human failing hearts, whereas PP2Ce pro-
tein, when expressed in cardiomyocytes, is acutely
induced by b-adrenergic stimulation and oxidative
stress. From extensive molecular and cellular
studies, we find that PP2Ce is a highly specific PLN
phosphatase with intrinsic activity toward PLN Thr-
17. Expression of PP2Ce in cardiomyocytes showed
a significant effect on SR calcium homeostasis,
particularly in calcium uptake, in line with its tar-
geted dephosphorylation of PLN. In addition, PP2Ce
expression both in vitro and in vivo promoted
oxidative injury and myocyte death. Therefore,
PP2Ce functions as an uncharacterized modulator for
cardiac calcium cycling and has a potentially signif-
icant contribution to stress adaption in the heart in
response to b-adrenergic stimulation and oxidative
injury.
PP2Ce protein is increased within 2 h in response
to acute b-adrenergic stimulation at the protein
level. PP2Ce protein is also affected by short-term
proteasome inhibition alone, and ISO-induced
PP2Ce protein induction requires de novo protein
synthesis. Therefore, PP2Ce protein homeostasis ismodulated by both synthesis and proteasome-
dependent degradation at the basal state. The un-
derlying mechanism of its turnover is unclear, and
the molecular signaling participated in ISO-mediated
PP2Ce protein induction remains to be established,
although our data suggest that it is a PKA-dependent
process. Interestingly, similar induction was
observed in oxidative stressed myocytes, suggesting
such induction can be triggered by different stressors
FIGURE 10 Induced PP2Ce Expression Promotes Cardiomyocyte Death in Response to I/R Injury
(A) Representative TTC staining cross section images from 1 PP2Ce TG and 1 control heart following 15 min of ischemia and 120 min of
reperfusion (I/R). (B) Infarct sizes of control (n ¼ 5) and PP2Ce TG (n ¼ 6) hearts as measured from (A). (C) Apoptotic index measured by
TUNEL staining in control (n ¼ 4) and PP2Ce TG (n ¼ 4) hearts. (D) Representative immunoblot for level of activated caspase 9 in control
(n ¼ 10) and PP2Ce TG (n ¼ 8) hearts following the same I/R protocol. (E) Quantification of level of cleaved caspase 9 signal from
immunoblots. *p < 0.05 between control and PP2Ce TG groups. **p < 0.01 between control and PP2Ce TG groups. Abbreviations as in
Figures 2 to 4.
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specific phosphatase in cardiomyocytes following
pathological stress offers an intriguing mechanism of
negative feedback regulation in cardiomyocytes to
maintain SR calcium homeostasis following stress
stimulations (Figure 12). Significant induction of
PP2Ce expression detected in human failing hearts
may represent a chronic maladaptation similar to
b-adrenergic desensitization.
We showed that, in a cell-free system, PP2Ce spe-
cifically dephosphorylated the Thr-17 site of PLN
but not the Ser-16 site, and PP2Ce expression did
not affect the phosphorylation status of other ERmembrane targeted proteins, such as RyR. This implies
that PP2Ce possesses a very high degree of intrinsic
substrate specificity. This contrasts with PP1, a major
PLN phosphatase with specificity toward both Ser-16
and Thr-17 sites, as well as other substrates. In addi-
tion, PLN dephosphorylation can also be carried out by
PP2A with its regulatory subunit B56. However, the
specificity of PP2A/B56 is also not limited to PLN. In
intact heart, however, PP2Ce expression affected both
Ser-16 and Thr-17 sites, suggesting that either PP2Ce
acquires new specificity in adult cardiomyocytes due
to a complex interaction that is yet to be characterized
or indirectly regulates Ser-16 phosphorylation.
FIGURE 11 PP2Ce Expression Promotes Myocytes Death and Perturbs Prosurvival Signaling Following Oxidative Injury
(A) NRVM viability measured by MTT assay in NRVM expressing GFP or PP2Ce following H2O2 treatment for 16 h at different doses as
indicated. Replicate number is labeled in each corresponding column. (B) NRVM viability expressing GFP (n ¼ 8) or PP2Ce (n ¼ 8) under
untreated or following 24 h of treatment of 2 mmol/l ionomycin. (C) Immunoblot analysis of intracellular signaling molecules as indicated in
NRVM-expressing GFP or PP2Ce with 50 mmol/l H2O2 treatment at different time points as indicated. Tunicamycin (5 mg/ml for 4 h) was used
as a control. (D) Quantification of signaling molecules as indicated with independent experimental replicate number labeled in each column.
**p < 0.01 versus untreated. ##p < 0.01 between GFP and PP2Ce groups at same doses. Abbreviations as in Figures 2 to 4.
Continued on the next page
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is consistent with the phenotype observed in the
PP2Ce-TG hearts, which displayed relatively normal
basal contractile function but showed blunted
inotropic response to ISO stimulation and more
susceptibility to I/R-induced injury. In fact, ourobservation is in good agreement with previous find-
ings that CaM kinase-mediated PLN regulation
(through Thr-17 phosphorylation) affects cardiac
injury following I/R. PP2Ce is also reported to regulate
IRE1-mediated unfold-protein response by specifically
interacting with and dephosphorylating IRE1 without
FIGURE 11 Continued
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178cross-reactivity toward PERK. In the heart, basal IRE1
expression is low (undetectable with current anti-
bodies, data not shown), whereas the PP2Ce expres-
sion is relatively abundant. Therefore, PP2Ce function
in heart may involve both substrates or other sub-
strates that are yet to be characterized. Further mo-
lecular studies will be needed to determine all possible
downstream targets of PP2Ce in the heart and to
uncover the underlying molecular basis for such a
high substrate specificity.CONCLUSIONS
Our extensive molecular, cellular, and molecular
analyses have revealed a previously uncharacterized
signaling regulator in the heart: an ER membrane-
targeted protein phosphatase with high specificity
toward PLN Thr-17 phosphorylation. Its induction
in human failing hearts and our in vivo evidence
from intact mouse hearts implicate its poten-
tial role in the pathogenesis of cardiac injury
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Defects in car-
diomyocyte calcium homeostasis and cycling significantly
contribute to cardiac dysfunction. PLN is a key regulator of
SERCA, and its function is modulated by PKA and CaMKII-
mediated protein phosphorylation; loss of PLN phosphorylation
is a molecular hallmark associated with heart failure. PP2Ce is a
newly identified phosphatase with potent and specific activity to
dephosphorylate PLN in cardiomyocytes.
TRANSLATIONAL OUTLOOK: PP2Ce expression is induced
rapidly after pathological stress, and PP2Ce induction has
negative effects on cardiac contractile function and cardiomyo-
cyte viability. Therefore, PP2Ce induction may represent a novel
mechanism for heart failure, and its inactivation can serve as a
potential therapeutic strategy.
FIGURE 12 Illustration of PP2Ce Function in Cardiac Myocytes
Abbreviations as in Figures 2 and 4.
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179through modulating SR calcium uptake and
homeostasis.
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